BFRIW

Biofrontera

• NASDAQ·10/08 13:47

  Biofrontera Submits Ameluz SNDA For Expanded Actinic Keratosis Use

• TipRanks·10/08 13:37

  Biofrontera submits sNDA to FDA to expand Ameluz indication

• Benzinga·10/08 13:24

  Biofrontera Refiles Supplemental New Drug Application For Ameluz Topical Gel To FDA To Treat Actinic Keratoses

• Benzinga·10/05 21:06

  12 Health Care Stocks Moving In Monday's After-Market Session

• NASDAQ·09/18 19:27

  Biotech Stocks In Focus - IMCC +245%, XRTX +12%, SILO, BFRI

• NASDAQ·09/14 14:08

  Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA

• TipRanks·09/14 13:58

  Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use

• TipRanks·09/14 13:35

  Biofrontera announces FDA approval of Ameluz supplemental new drug application

• Benzinga·09/14 13:31

  Biofrontera Receives FDA Supplemental New Drug Application Approval For Its Ameluz Topical Gel, 10%, In Combination With Photodynamic Therapy Using The BF-RhodoLED Lamp Series For The Treatment Of Superficial Basal Cell Carcinoma In Adults

• Benzinga·09/11 12:06

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• TipRanks·09/10 15:55

  FDA approves label update for Biofrontera’s Ameluz Gel

• Benzinga·09/10 15:35

  FDA Approves Label Update For Biofrontera’s Ameluz Gel To Highlight Hypersensitivity Warnings

• NASDAQ·09/08 04:11

  ISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision

• NASDAQ·09/08 02:28

  Biotech Stocks At 52-Week Highs - PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTS

• NASDAQ·08/31 09:01

  Biotech Stocks At 52-Week Highs - RNXT +12%, BLSM, RVTY, ATRC, BFRI